NCT04506320View on ClinicalTrials.gov

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Multiple MyelomaStem Cell Transplant
Trial Locations (2)

Unknown

Azienda Ospedaliera di Careggi, Florence

Clinica Ematologica - Policlinico Universitario, Udine

All Listed Sponsors
collaborator

Azienda Ospedaliero-Universitaria Careggi

OTHER

lead

Gruppo Italiano Trapianto di Midollo Osseo

OTHER

NCT04506320 - Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter